VetDC - Ft. Collins, CO since Feb 2010
President & CEO
ENTROPY2ACTION, LLC Sep 2009 - Feb 2010
Co-Founder
AMGEN INC. Jan 2004 - Nov 2007
Director, Licensing/Alliance Management
AMGEN INC Jan 2001 - Dec 2003
Sr. Associate Director, Aranesp Oncology Planning & Operations
AMGEN INC. Jan 1999 - Jan 2001
Associate Director, Market Research
Education:
University of Michigan - Stephen M. Ross School of Business 1992 - 1994
MBA, Marketing, Finance
UNIVERSITY OF CALIFORNIA AT SAN DIEGO 1983 - 1987
Bachelor of Arts, Molecular Biology
Skills:
Biotechnology Veterin Veterinary Strategic Alliances Biopharmaceuticals Oncology Lifesciences Pharmaceutical Industry Commercialization Technology Transfer Clinical Development Drug Discovery Drug Development Clinical Trials Infectious Diseases Medical Devices Licensing Immunology FDA Molecular Biology Regulatory Affairs CRO R&D
VetDC Wins Venture Showcase Competition at BioWest 2012 Colorado BioScience Association (CBSA) DENVER, Sep 12, 2012 (BUSINESS WIRE) -- VetDC (Fort Collins) won the 2012 Venture Showcase competition at the 2012 BioWest Conference & Expo yesterday at the Marriott City Center Denver, receiving the $7,500 cash prize. The announcement is made by April Giles, Colorado BioScience Association (CBSA) Executive Vice President who says this year's Venture Showcase was made possible by sponsors Dorsey & Whitney LLP, EKS&H and The Metro Denver Economic Development Corporation. BioWest, the Rocky Mountain Region's premier medical device and biotechnology conference, is organized by the CBSA and held every other year.
VetDC is an emergent veterinary biotechnology company that licenses innovative human biomedical technologies to address serious medical needs in companion animals. By aligning with CSU's top-ranked veterinary school, VetDC has unique capabilities to develop animal therapies, resulting in speed to market, risk reduction, and capital preservation. VetDC has assembled a proven team with regulatory, CMC, and clinical expertise. VetDC's lead candidate, VDC-1101, is an anti-cancer drug with extensive animal data. VDC-1101 is expected to launch in 2014 with $50M peak revenue potential. In 2011, VetDC secured funding from the Colorado Institute for Drug, Device and Diagnostic Development (CID4). VetDC President/CEO Steven Roy made the presentation at the Venture Showcase. For more information, visit: http://www.vet-dc.com .
"The Venture showcase announcement is the capstone to the BioWest Conference," Giles explains. "It creates a huge buzz in the industry for the up-and-coming companies chosen to compete. We are very proud to announce VetDC as this year's winner."
William Carey University 1993 - 1994
Bachelors, Nursing
Interests:
Casinos Exercise Sweepstakes Home Improvement Reading Sports Hockey Watching Hockey Home Decoration Watching Sports Cooking Electronics Music Dogs Movies Kids Travel Investing Traveling Smoking
Sep 2010 to 2000 Fleet MechanicParker Adventist Hospital Parker, CO Oct 2003 to Jul 2009 Material HandlerLucent Technologies Denver, CO Jan 2000 to Feb 2003 InstallerStephens Equipment Franktown, CO Sep 1996 to Oct 1997 MechanicDuwald Steel Denver, CO Jul 1995 to Aug 1996 Fleet Mechanic
Education:
College America Denver, CO Jan 1998 to Jan 1999 certificate in Computer RepairWilson Tech center Dix Hills, NY Jan 1984 to Jan 1985 Certificate of Arc Welding one in Arc WeldingDenver Auto and Diesel College Denver, CO Jan 1980 to Jan 1982 Associates Degree in Occupational Business in Auto and Diesel Repair
Skills:
mechanical skils,maintain and repair cars,trucks,forklifts,bobcats,... and receiving,stocking hospitals,